INFINITY L&T(01442.HK)擬增發6400萬股籌資8800萬港元
格隆匯6月29日丨INFINITY L&T(01442.HK)公吿,於2021年6月29日,公司(作為發行人)與各認購人(狄衞一先生、Loh Yu Meng先生、Ang Poon Ling女士及Goo Li Siang女士)訂立認購協議,內容有關按認購價每股認購股份1.38港元(較6月29日收市價每股1.38港元並無折讓或溢價)認購合共6400萬股認購股份。
認購事項估計所得款項淨額(扣除開支後)將約為8800萬港元。公司擬將該等所得款項淨額用作集團的一般營運資金,主要用於投資及發展業務、擴大船隊以及一般企業開支。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.